[9]FiftyPercentofPatientswithUlcerativeColitisTreatedwithMirikizumabAchievedClinicalRemissionatOneYearinLilly'sPivotalPhase3Study.RetrievedMay24,2022,fromhttps://www.prnewswire.com/news-releases/fifty-percent-of-patients-with-ulcerative-colitis-treated-with-mirikizumab-achieved-clinical-remission-at-one-year-in-lillys-pivotal-phase-3-study-301552268.html
[10]PfizerAnnouncesPositiveTop-lineResultsfromYearlongPhase3TrialofEtrasimodinUlcerativeColitis,UnderscoringBest-in-ClassPotential.RetrievedMarch29,2022,fromhttps://www.businesswire.com/news/home/20220329005198/en
[11]MerckAnnouncesPositiveTop-lineResultsfromPivotalPhase3STELLARTrialEvaluatingSotaterceptfortheTreatmentofAdultswithPulmonaryArterialHypertension(PAH).RetrievedOctober10,2022,fromhttps://www.merck.com/news/merck-announces-positive-top-line-results-from-pivotal-phase-3-stellar-trial-evaluating-sotatercept-for-the-treatment-of-adults-with-pulmonary-arterial-hypertension-pah/
- 2022年循梦前行，2023年前路可期
- 2023年跨年的断想
- 2023年元旦跨年，精选30句精选朋友祝福语送给你，愿所求皆圆满
- 名单公布！国家药监局批准！
- N95口罩的 “N” 是啥意思？
- 奋进新征程 共筑健康梦——《保健时报》2023年新年寄语
- 默沙东公司新冠病毒治疗药物莫诺拉韦胶囊在中国获批
- 到2023年，奉劝各位男性朋友们：身上这个部位得好好保养了！
- 东昌妇幼获批成为残疾评定机构并开展首次残疾人评定工作
- 第二款进口新冠口服药获批上市，默沙东能填补辉瑞紧缺困局吗